Literature DB >> 15356045

Prolactin release is enhanced in proportion to excess visceral fat in obese women.

Petra Kok1, Ferdinand Roelfsema, Marijke Frölich, A Edo Meinders, Hanno Pijl.   

Abstract

Prolactin (PRL) promotes (visceral) fat accrual in a variety of animal models. The release of PRL by the pituitary is tonically inhibited by dopamine through activation of the dopamine D2 receptor (D2R) of lactotroph cells, and obese humans appear to have reduced D2R-binding sites in their brain. Therefore, we hypothesized that spontaneous PRL release is enhanced in obese humans. To evaluate this hypothesis, we measured 24-h plasma PRL concentrations at 10-min intervals in 11 obese premenopausal women [body mass index (BMI), 33.3 +/- 0.7 kg/m(2)] and 10 lean premenopausal women of similar age (BMI, 21.2 +/- 0.6 kg/m(2)). Total body fat was determined using dual energy x-ray absorptiometry, and sc and visceral fat area was measured by magnetic resonance imaging in 10 obese subjects. PRL secretion rate was estimated by deconvolution analysis. All subjects were studied in the early follicular stage of their menstrual cycle. PRL secretion was significantly enhanced in obese women (total daily release, 137 +/- 8; lean controls, 92 +/- 8 microg/liter.24 h; P = 0.001) in proportion to their BMI (r(2) = 0.55; P < 0.001). Interestingly, PRL release was particularly associated with the size of the visceral fat mass (total PRL secretion vs. visceral fat area, r(2) = 0.64; P = 0.006). These data show that spontaneous PRL release is considerably enhanced in obese women in proportion to the size of their visceral fat mass. Because PRL is inhibited by D2R activation we speculate that elevated PRL secretion may be due to reduced D2R availability in the brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356045     DOI: 10.1210/jc.2003-032184

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  30 in total

1.  Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults.

Authors:  C D Gibson; W Karmally; D J McMahon; S L Wardlaw; J Korner
Journal:  Diabetes Obes Metab       Date:  2011-12-27       Impact factor: 6.577

Review 2.  Management of obesity in the elderly: too much and too late?

Authors:  R L Kennedy; U Malabu; M Kazi; V Shahsidhar
Journal:  J Nutr Health Aging       Date:  2008-11       Impact factor: 4.075

Review 3.  Changes in pituitary function with ageing and implications for patient care.

Authors:  Johannes D Veldhuis
Journal:  Nat Rev Endocrinol       Date:  2013-02-26       Impact factor: 43.330

4.  Maternal prepregnancy waist circumference and BMI in relation to gestational weight gain and breastfeeding behavior: the CARDIA study.

Authors:  Helene Kirkegaard; Ellen A Nohr; Kathleen M Rasmussen; Henrik Stovring; Thorkild I A Sørensen; Cora E Lewis; Erica P Gunderson
Journal:  Am J Clin Nutr       Date:  2015-07-01       Impact factor: 7.045

5.  Is prolactin the missing link in adipose tissue dysfunction of polycystic ovary syndrome patients?

Authors:  Alice Albu; Suzana Florea; Simona Fica
Journal:  Endocrine       Date:  2015-06-12       Impact factor: 3.633

6.  Regulation of prolactin in mice with altered hypothalamic melanocortin activity.

Authors:  Roxanne Dutia; Andrea J Kim; Eugene Mosharov; Eriika Savontaus; Streamson C Chua; Sharon L Wardlaw
Journal:  Peptides       Date:  2012-07-16       Impact factor: 3.750

Review 7.  Minireview: Extrapituitary prolactin: an update on the distribution, regulation, and functions.

Authors:  Robert J Marano; Nira Ben-Jonathan
Journal:  Mol Endocrinol       Date:  2014-04-02

8.  Evaluation of insulin sensitivity in hyperprolactinemic subjects by euglycemic hyperinsulinemic clamp technique.

Authors:  Alpaslan Tuzcu; Serkan Yalaki; Senay Arikan; Deniz Gokalp; Mithat Bahcec; Sadiye Tuzcu
Journal:  Pituitary       Date:  2009-05-01       Impact factor: 4.107

Review 9.  The effects of hyperprolactinemia on bone and fat.

Authors:  Amal Shibli-Rahhal; Janet Schlechte
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

10.  Bone density in women with prolactinoma treated with dopamine agonists.

Authors:  Erika Cesar de Oliveira Naliato; Alice Helena Dutra Violante; Dayse Caldas; Maria Lucia Fleiuss Farias; Isabela Bussade; Adilson Lamounier Filho; Christiane Rezende Loureiro; Rosita Fontes; Yolanda Schrank; Thaissa Loures; Annamaria Colao
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.